Position in RNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$926,460
New position
Shares Held
69,294
first reported quarter
Ownership
0.405%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 1%
Shared 0%
None 99%
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEUBERGER BERMAN GROUP LLC holds $1,136,881,142 across 81 Biotechnology names. RNA ranks #43 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,129 | $330,016,949 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,522 | $246,276,633 | |
| 3 | TECH |
BIO-TECHNE Corp
|
3,340,837 | $174,592,141 | |
| 4 | CAI |
Caris Life Sciences, Inc.
|
3,590,586 | $64,199,677 | |
| 5 | INSM |
INSMED Inc
|
270,700 | $44,264,863 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
443,272 | $33,285,294 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
93,496 | $30,935,021 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
480,740 | $25,344,612 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $926,460 | 69,294 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||